Cite

HARVARD Citation

    Spain, L. et al. (2016). Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations. Expert opinion on pharmacotherapy. pp. 1031-1038. [Online]. 
  
Back to record